EGFR and neoplasm: The clinicopathological characteristics of the patients, including age, gender, clinical stage, tumor differentiation, tumor size, BMI, smoking history, Eastern Cooperative Oncology Group (ECOG) performance status, EGFR mutation status, baseline serum CEA levels, and relapse CEA levels, were detailed in Table 1.